Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States

Blood20.30
Volume: 128, Issue: 26, Pages: 3043 - 3051
Published: Dec 29, 2016
Abstract
Despite the availability of multiple nonheparin anticoagulants for the treatment of heparin-induced thrombocytopenia (HIT), few data are available comparing the cost-effectiveness of these agents. This analysis is particularly important when considering differences in the risk of adverse effects, routes of administration, requirements for phlebotomy and laboratory monitoring, and overall drug costs. We conducted a cost-effectiveness analysis of...
Paper Details
Title
Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States
Published Date
Dec 29, 2016
Journal
Volume
128
Issue
26
Pages
3043 - 3051
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.